chr2-70979254-T-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001115116.2(ANKRD53):āc.328T>Gā(p.Tyr110Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00024 in 1,613,722 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001115116.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKRD53 | NM_001115116.2 | c.328T>G | p.Tyr110Asp | missense_variant | 2/6 | ENST00000360589.4 | |
LOC105374795 | XR_001739534.2 | n.440-2946A>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKRD53 | ENST00000360589.4 | c.328T>G | p.Tyr110Asp | missense_variant | 2/6 | 2 | NM_001115116.2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152262Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000232 AC: 58AN: 250418Hom.: 1 AF XY: 0.000243 AC XY: 33AN XY: 135692
GnomAD4 exome AF: 0.000242 AC: 353AN: 1461344Hom.: 3 Cov.: 35 AF XY: 0.000243 AC XY: 177AN XY: 726968
GnomAD4 genome AF: 0.000223 AC: 34AN: 152378Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74524
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.328T>G (p.Y110D) alteration is located in exon 2 (coding exon 2) of the ANKRD53 gene. This alteration results from a T to G substitution at nucleotide position 328, causing the tyrosine (Y) at amino acid position 110 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at